96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00989573
(ClinicalTrials.gov)
October 20092/10/2009A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's DiseaseA Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's DiseaseCrohn's DiseaseDrug: Placebo;Drug: OPC-6535Otsuka Pharmaceutical Co., Ltd.NULLCompleted18 Years64 YearsBoth191Phase 2;Phase 3Japan;Korea, Republic of
2NCT00317369
(ClinicalTrials.gov)
May 200621/4/2006A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's DiseaseA Dose-Finding Study of OPC-6535 in Patients With Active Crohn's DiseaseCrohn DiseaseDrug: OPC-6535(Tetomilast)Otsuka Pharmaceutical Co., Ltd.NULLTerminated16 Years65 YearsBoth60Phase 2Japan